论文信息 - Nivolumab Treatment Beyond Investigator-Assessed Progression: Extended Follow-up in Patients with Relapsed/Refractory Classical Hodgkin Lymphoma from the Phase 2 CheckMate 205 Study - 字舞流文

Nivolumab Treatment Beyond Investigator-Assessed Progression: Extended Follow-up in Patients with Relapsed/Refractory Classical Hodgkin Lymphoma from the Phase 2 CheckMate 205 Study

K. Savage | M. Shipp | A. Santoro | P. Zinzani | P. Armand | A. Younes | S. Ansell | J. Kuruvilla | J. Timmerman | M. Trněný | O. Sy | A. Engert | R. Ramchandren | H. Lee | G. Collins | J. Boer | J. Cohen | M. Sacchi